2.3.1.135	13-demethyl-13,14-dihydro-all-trans-retinyl trifluoroacetate	competitive with respect to dipalmitoylphosphocholine, uncompetitive with respect to all-trans-retinol; reversible inhibitor	45057	
2.3.1.135	all-trans-retinyl-alpha-bromoacetate	irreversible inhibition	51510	
2.3.1.135	all-trans-retinyl-alpha-bromoacetate	-	51510	
2.3.1.135	all-trans-retinylbromoacetate	-	56930	
2.3.1.135	Apo-cellular-retinol-binding protein	-	98917	
2.3.1.135	apo-CRBP-I	i.e. apo-[cellular retinol-binding protein I], no inhibition by apo-CRBP-III	135401	
2.3.1.135	fenretinide	used clinically to presumably lower blood retinol-binding protein levels and thus decrease circulating retinol, targets the functional coupling of STRA6 and LRAT to increase cellular vitamin A uptake in peripheral tissues	32884	
2.3.1.135	additional information	inactivated by trivalent arsenicals	2	
2.3.1.135	additional information	1% dimethylsulfoxide does not inhibit LRAT activity	2	
2.3.1.135	additional information	1-acyl-lysophosphatidylcholine does not inhibit LRAT up to 0.020 mM; product inhibition by retinyl ester can be ruled out	2